MIX · HEAL · BOOST
Introducing ReadyMedical, the first professional line of ready-to-mix sterile products which are specifically formulated to support and enhance the results of medical-aesthetic procedures and to promote effective healing. ReadyMedical offers four targeted solutions that are specially designed to perfect your aesthetic treatments and boost results.
How it Works
ReadyMedical features a unique mixing system that allows you to combine sterile hyaluronic acid with a complex of therapeutic ingredients of your choice, at the moment of application.
Sterile.
No Preservatives.
Highly Potent.
The unique mixing system ensures that:
- The ingredients remain stable and highly potent in the package
- The products contain higher concentrations of active ingredients
- The ingredients are sterile
- No preservatives are added
- The products can be safely applied on any skin, including open wounds and bleeding areas
Perfecting Every Treatment
Ready-to-Mix Sterile Healing Solutions
Sonicated Hyaluronic Acid
Our 100% preservative-free hyaluronic acid is mechanically fragmented into low, medium and high molecular weight by ultrasonic waves, without any chemicals.
Boosted Results:
- Carries the active ingredients into the skin and maintains potency
- Intensively hydrates the skin
- Deactivates free radicals
ReadyMedical SOLUTIONS
Anti-Aging Solution
Hyaluronic Acid + Growth Factors
Antioxidant Solution
Hyaluronic Acid + Vitamin C
Skin Healing Solution
Hyaluronic Acid+Perfluorodecalin+Physalis Angulata
ACNYCID SOLUTION
Hyaluronic Acid + AC Complex
Anti-Aging Solution
Hyaluronic Acid + Growth Factors
ReadyMedical Anti-Aging Solution maximizes the effect of professional anti-aging treatments. The growth factors are made in a unique process that mimics the activity of native growth factors, with 100% biocompatibility and improved potency and stability.
Skin Healing Solution
Hyaluronic Acid+Perfluorodecalin+Physalis Angulata
ReadyMedical Skin Healing Solution provides a powerful wound-healing effect after more invasive medical-aesthetic treatments when quick skin repairing is needed.
An independent study[2] by the University of Pavia, Italy, found that inflamed fibroblasts treated with ReadyMedical Skin Healing Solution demonstrated dramatic and significant decrease in the production of pro-inflammatory cytokines when compared to untreated fibroblasts.
Antioxidant Solution
Hyaluronic Acid + Vitamin C
ACNYCID SOLUTION
Hyaluronic Acid + AC Complex
Designed to be used immediately after professional in-clinic treatments that aim to improve the quality of acne-affected skin.
An independent study[4] by the University of Pavia, Italy, found that p. acne bacterial loads were reduced by 99.9% after the bacteria was exposed to ReadyMedical Acne Solution, suggesting long-term inhibition of the bacteria.
WHEN TO USE ReadyMedical
ReadyMedical is to be used immediately after lasers, IPLs, radio-frequency, micro-needling and virtually any kind of treatment that is offered in your clinic. ReadyMedical can also be used at home, between sessions, to reduce downtime and improve overall results.
USE AFTER
Anti-Aging Solution
- Radio-frequency
- Micro-needles
- Micro-needles with RF
- Peelings
- Alternative to blood extraction treatment
Skin Healing Solution
- Intensive lasers and IPLs
- Ablative procedures
- Tattoo removal
- Strong chemical peels
- Directly on bleeding skin
Antioxidant Solution
- Exfoliations
- Mesotherapy
- Radio-frequency
- Micro-needles
- Micro-needles with RF
ACNYCID Solution
- Peelings
- Exfoliations
- Extractions
- Micro-needles
- Directly on active lesions
See the Results for Yourself
THE SCIENCE BEHIND ReadyMedical
The efficacy of all ReadyMedical products has been proven by clinical tests that were performed by an impartial laboratory at the University of Pavia, Italy.
The results below demonstrate the performance of the active ingredients at different stages of the healing process, in comparison to control samples which were not treated with ReadyMedical.
SUMMARY
This study evaluated the proliferation enhancement of human fibroblasts that were treated with ReadyMedical HA + GF in-vitro. The cells were cultured in a special system that simulate wound environment, and tested the ability of the treated cells to close the “wound” (i.e. the motility rate of the cells). 3 different treatment were evaluated:
- Untreated fibroblasts (control)
- Fibroblasts treated with HA+GF 75 mg/ml
- Fibroblasts treated with HA+GF 100 mg/ml
The results show that 48h after the treatment, fibroblasts that were treated with ReadyMedical HA + GF were able to close the wound 44% faster than untreated fibroblasts.
SUMMARY
This study evaluated the anti-inflammatory impact in human fibroblasts that were treated with ReadyMedical Repairing HA+PFD+PA in-vitro.
Fibroblasts cells were cultured in a special environment that trigger their inflammatory response. To quantify the level of inflammation, the study measured the level of the pro-inflammatory cytokine IL-8, which is the most direct and reliable marker of inflammation among the wide cytokine family.
The cells were then treated with ReadyMedical Repairing HA+PFD+PA, and the levels of IL-8 were measured after 24h.
The results show that inflamed fibroblasts which were treated with HA+PFD+PA demonstrated a dramatic and significant decrease in the production of IL-8 when compared to the control group, indicating the strong anti-inflammatory and pro-healing effect of ReadyMedical Repairing HA+PFD+PA.
SUMMARY
This study evaluated the ability of ANTIOXIDANT HA + VIT C to prevent the formation of free radicals (ROS) and protect skin cells from photodamage.
Human keratinocytes were treated with ANTIOXIDANT HA + VIT C and then exposed to UV radiation. The efficacy of the product was measured in correlation to the level of ROS following different exposure durations to the radiation at different concentrations of the product.
The results show that even at low product concentration (0.0313 mg/ml), the production of ROS was virtually halted and the cells were protected from the UV damage.
SUMMARY
This study evaluated the ability of ACNE HA + AC to reduce the growth of the P. acne bacteria, which is responsible for the onset of acne vulgaris.
The bacteria was incubated in physiological conditions for 48h, and then treated with ACNE HA + AC. To determine the anti-bacterial capacity of the product, the bacterial load was measured 6h & 24h after the treatment.
The results show that the bacterial load is reduced by 99.9% after 6h following the treatment. This result remains consistent 24h after the treatment, suggesting long-term inhibition of the bacteria.
